# Phase II Artesunate Study in Severe Malaria

> **NCT00522132** · PHASE2 · COMPLETED · sponsor: **Medicines for Malaria Venture** · enrollment: 200 (estimated)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Artesunate

## Key facts

- **NCT ID:** NCT00522132
- **Lead sponsor:** Medicines for Malaria Venture
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2008-06
- **Final completion:** 2008-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2011-09-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00522132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00522132, "Phase II Artesunate Study in Severe Malaria". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00522132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*